Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPO | P05164 | 12/20 | 0.67 |
| ▸ | TPO | P07202 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.39 |
| ▸ | SLC2A1 | P11166 | 4/20 | 0.38 |
| ▸ | HTR6 | P50406 | 2/20 | 0.35 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18618817 | 0.91 | MPO (0.67) | MPOTPOCYP3A4SLC2A1HTR6 | |
| SCHEMBL18618797 | 0.88 | MPO (0.67) | MPOSLC2A1HTR6 | |
| SCHEMBL18620643 | 0.82 | MPO (0.55) | MPOSLC2A1 | |
| SCHEMBL18620072 | 0.80 | MPO (0.66) | MPOTPOCYP3A4CYP11B1CYP11B2 | |
| SCHEMBL18620076 | 0.80 | MPO (0.70) | MPOTPOCYP3A4CYP11B1CYP11B2 | |
| SCHEMBL18618875 | 0.73 | MPO (0.55) | MPOTPOCYP3A4CYP11B1CYP11B2 | |
| SCHEMBL18618819 | 0.73 | MPO (0.51) | MPOTPOCYP3A4 | |
| SCHEMBL18618931 | 0.72 | MPO (0.63) | MPOSLC2A1HTR6 | |
| SCHEMBL18586841 | 0.72 | MPO (0.68) | MPOTPOCYP3A4SLC2A1HTR6 | |
| SCHEMBL18586833 | 0.71 | MPO (0.70) | MPOTPOCYP3A4SLC2A1HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017040451-A1 | TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2017-03-09 | — | — | WO | disclosed |